Selection for genome instability by DNA damage in human cells: Unstable microsatellites and their consequences for tumourigenesis

Radiation Oncology Investigations

Volumn 5, Issue 3, 1997, Pages 111-114

  Hampson, Richard ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

DNA damage resistance; DNA mismatch repair; Microsatellite instability

Indexed keywords

MICROSATELLITE DNA;

BASE MISPAIRING; CANCER GENETICS; CARCINOGENESIS; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BASE COMPOSITION; BASE SEQUENCE; CHROMOSOME ABERRATIONS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DRUG RESISTANCE, NEOPLASM; FRAMESHIFT MUTATION; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HUMANS; MICROSATELLITE REPEATS; MUTATION; NEOPLASMS; PHENOTYPE; REPETITIVE SEQUENCES, NUCLEIC ACID; RISK FACTORS;

EID: 0030747769     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1997)5:3<111::AID-ROI5>3.0.CO;2-0     Document Type: Conference Paper

References (16)

1. Simon SM, Schindler M: Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91:3497-3504, 1994.
2. Swann PF, Waters TR, Moulton DC, Xu Y-Z, Zheng Q, Edwards M, Mace R: Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273:1109-1111, 1996.
3. Anthoney DA, Mcllwrath JA, Galagher WM, Edlin ARM, Brown R: Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56:1374-1381, 1996.
4. Karran P, Hampson R: Genomic instability and tolerance to alkylating agents. Cancer Surveys 28:69-85, 1996.
5. Modrich P, Lahue R: Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu Rev Biochem 65:101-133, 1996.
6. Modrich P: DNA mismatch correction. Annu Rev Biochem 56:435-466, 1987.
7. Shibata D, Peinado MA, Ionov Y, Malkosyan S, Perucho M: Genomic instability in repeated sequences is an early somatic event in clorectal tumorigenesis that persists after transformation. Nature Genet 6:273-281, 1994.
8. Lichtenauer-Kaligis EGR, Thijssen J, den Dulk H, van der Putte P, Tasseron-de Jong JG, Giphart-Gassler M: Genome wide spontaneous mutation in human cells determined by the spectrum of mutations in hprt cDNA. Mutagenesis 8:207-220, 1993.
9. Lynch HT, Smyrk T: Hereditary nonpolyposis colorectal cancer (Lynch syndrome) - An updated review. Cancer 78:1149-1167, 1996.
10. Bicknell DC, Kaklamanis L, Hampson R, Bodmer WF, Karran P: Selection for β2-microglobulin mutation in mismatch-repair defective colorectal carcinomas. Curr Biol 6:1695-1697, 1996.
11. Branch P, Bicknell DC, Rowan A, Bodmer WF, Karran P: Immune surveillance in colorectal carcinoma. Nat Genet 9:231-232, 1995.
12. Markowitz S, Wang J, Myerhoff L, Parsons R, Sun, Lutterbaugh L, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV: Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
13. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou T-T, Shi Y-Q, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Legget B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nature Genet 14:255-257, 1996.
14. Malkhosyan S, Rampino N, Yamamoto H, Perucho M: Frameshift mutator mutations. Nature 382:499-500, 1996.
15. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079, 1991.
16. Karran P: Appropriate partners make good matches. Science 268:1857-1858, 1995.